13 penny stocks plunge up to 90% in FY26. Are you affected?

AI Analysis

While the article doesn't name specific pharma penny stocks, the general caution against penny stocks applies across all sectors, including pharma. Investors should be wary of speculative plays even in sectors with positive outlooks.

Trading Insight

Avoid speculative penny stock investments in the pharma sector; focus on fundamentally strong companies with clear product pipelines and regulatory compliance.

Key Evidence

•13 penny stocks plunged between 50% and 90% in FY26.
•These stocks were screened for liquidity and size, indicating their vulnerability.
•The declines underscore volatility, weak transparency, and manipulation concerns in penny stocks.
•Investments in such equities demand disciplined strategies and strong risk management to avoid significant capital erosion.
•Risk flag: Lack of transparency and potential for manipulation in penny stocks.

AI-powered analysis by

Anadi Algo News